Open original FDA record ↗Recall record
- FDA identifier
- Z-1201-2021
- Company in FDA record
- Medtronic Vascular, Inc.
- FDA record creation date
- Mar 10, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
Due to the presence of type IIIb endoleaks, stent fractures, and stent ring enlargement.
Source facts
- Action
- On or about 02/12/2021, the Recalling Firm initiated global verbal notifications to customers (risk managers and physicians) to immediately cease implants and quarantine any unused affected products.
- Initiated
- 2021-02-12
- Root cause
- Under Investigation by firm
- Distribution
- Worldwide distribution. US Nationwide, Italy, Denmark, Germany, Finland, Chile, Russian Federation, Norway, South Africa, New Zealand, Australia, United Kingdom, Switzerland, Austria, Netherlands, Spain, Portugal, France, Israel, Greece, Thailand, Ireland, Colombia, Canada, Hong Kong, Sweden, Belgium, Saudi Arabia, Malaysia, Singapore, Brazil, Macau, Luxembourg, Viet Nam, Taiwan, Croatia, Serbia, United Arab Emirates, Slovenia, Philippines, Poland, Japan, Costa Rica, Hungary, Korea, Slovakia, Malta, Bahrain, Kuwait, Qatar, Reunion, Honduras, Mauritius, India, Peru, El Salvador, Ukraine, Uruguay, Trinidad and Tobago.
- Recall number
- Z-1201-2021
- Recall status
- Open, Classified
- CDRH record ID
- 185929
- FDA record created
- 2021-03-10
- Recall event number
- 87379